Olsalazine was not better than placebo in maintaining remission in inactive Crohn disease
- PMID: 11985433
- DOI: 10.7326/acpjc-2002-136-3-092
Olsalazine was not better than placebo in maintaining remission in inactive Crohn disease
Comment on
-
Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study.Gut. 2001 Oct;49(4):552-6. doi: 10.1136/gut.49.4.552. Gut. 2001. PMID: 11559654 Free PMC article. Clinical Trial.